With the artificial intelligence trade experiencing heightened volatility, many investors are seeking to rebalance their portfolios by shifting capital into sectors that offer more stable, fundamentals-driven growth. Market strategists at UBS have highlighted a rotation into quality defensive and value stocks as a prudent approach to diversification, particularly as AI infrastructure and semiconductor indices face corrections.
Below are three stocks that combine robust financial performance with defensive characteristics, making them attractive candidates for investors looking to reduce exposure to the AI boom while maintaining growth potential.
Eli Lilly (LLY)
Eli Lilly stands out as a secular growth powerhouse insulated from the cyclicality of the tech sector. The company's dominance in the GLP-1 weight-loss and diabetes market provides a formidable moat against macroeconomic headwinds. In the first quarter, Eli Lilly reported worldwide revenue of $19.8 billion, a 56% year-over-year surge, driven primarily by its blockbuster drugs Mounjaro and Zepbound, which together generated $12.8 billion. Mounjaro revenue alone jumped 125% year-over-year, propelling non-GAAP earnings per share to $8.55—a 156% increase. Management recently raised its full-year sales guidance by $2 billion, projecting up to $85 billion. This explosive growth and pricing power make Eli Lilly a premier non-tech asset for investors seeking exposure to secular healthcare trends.
McDonald's (MCD)
McDonald's exemplifies a defensive equity that attracts institutional capital rotating into traditional value sectors. The fast-food giant's ability to command pricing power and maintain consumer traffic regardless of the economic climate is a key driver. In the first quarter, McDonald's delivered its strongest top-line performance in eight quarters, with total revenue reaching $6.5 billion, a 9.4% year-over-year increase. Worldwide comparable sales grew 3.8% across all segments, supported by targeted value campaigns that consistently outpace competitors in gaining market share. Operating margins expanded to 45.3%, pushing adjusted earnings per share to $2.83. For investors building a protective portfolio, McDonald's offers recession-resistant fundamentals that can weather market froth.
Charles Schwab (SCHW)
Charles Schwab rounds out this diversification strategy as a financial sector standout that provides an excellent hedge against tech exposure. The bullish thesis rests on accelerating net interest revenues, massive asset-gathering capabilities, and stabilizing funding costs. In the first quarter, sales climbed to $6.5 billion, reflecting a 15.7% year-over-year increase. Schwab is reducing its reliance on higher-cost bank supplemental funding while attracting billions in core net new assets and expanding active brokerage accounts. With forward projections pointing toward a 16% year-on-year rise in net interest revenue, Schwab capitalizes effectively on a stabilizing rate environment. A 1.25% dividend yield adds to the appeal for income-focused investors in 2026.
For more context on the broader market rotation, see our coverage of Intel and AMD Stocks Slide on Overcapacity Fears and Rotation Out of AI Hardware and Memory Chip Stocks Slide as TSMC's Capex Hike Triggers Broader Semiconductor Selloff.
These three stocks offer a compelling mix of defensive strength and growth potential, providing investors with a strategic alternative to the concentrated AI trade as earnings season approaches.
This article is for informational purposes only and does not constitute financial advice.
